Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Government gives green light for second runway at Gatwick

(Sharecast News) - Transport secretary Heidi Alexander has signed off a second runway at London Gatwick, which the airport hopes will facilitate another 100,000 flights a year. The privately financed project, worth £2.2bn, will see the current northern runway move 12 metres so that it can be used simultaneously as the main runway.

Currently, the northern runway is only used as an emergency runway for taxiing aircraft, or as a backup when the main runway is closed, as it it too close to the main runway.

The government said the project was a "no-brainer" for the economy, which will add 14,000 jobs and generate £1bn a year.

The plans have been in place since February, though the airport has since agreed to noise mitigation and enhanced public transportation measures following concerns from local communities and planning inspectors.

Gatwick, which currently runs 280,000 flights each year, is expected to handle up to 390,000 by the late-2030s under the current plans.

"The transport secretary has cleared Gatwick expansion for take-off. With capacity constraints holding back business, trade and tourism, this is a no-brainer for growth," a government source said.

"This government has taken unprecedented steps to get this done, navigating a needlessly complex planning system, which our reforms will simplify in future."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.